Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
0.8132
-0.0267 (-3.18%)
At close: Nov 6, 2026, 4:00 PM EST
0.8500
+0.0368 (4.53%)
After-hours: Nov 6, 2026, 7:30 PM EST

Organogenesis Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
352.05564.17482.04433.14450.89467.36
Revenue Growth
-24.33%17.04%11.29%-3.94%-3.52%38.15%
Gross Profit
235.97431.83366.3326.66345.87353.16
Operating Income
-79.6361.5721.5216.3224.5772.94
Net Income
-153.1520.02-0.944.9515.5394.2
Earnings Per Share
-1.200.15-0.010.040.120.70
EPS Growth
----68.44%-82.94%366.67%

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
21.3395.92135.88104.71102.48113.93
Total Debt
64.5282.1443.31121.68126.25136.27
Net Cash (Debt)
-43.1913.7992.57-16.97-23.78-22.34
Net Cash Growth
--85.11%----
Net Cash Per Share
-0.340.110.70-0.13-0.18-0.17

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
10.3-10.3114.2130.9224.8661.98
Capital Expenditures
-10.36-14.15-10.03-24.36-33.9-31.22
Free Cash Flow
-0.06-24.464.186.55-9.0430.76
Free Cash Flow Growth
---36.27%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.03%76.54%75.99%75.42%76.71%75.56%
Operating Margin
-22.62%10.91%4.46%3.77%5.45%15.61%
Pretax Margin
-24.30%8.33%-0.58%2.40%4.50%13.50%
Profit Margin
-43.50%3.55%-0.19%1.14%3.45%20.16%
FCF Margin
-0.02%-4.34%0.87%1.51%-2.00%6.58%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-32.83-108.6122.6712.62
Forward PE
-24.6758.18136.3311.9623.39
P/FCF Ratio
--96.3481.96-38.65
PS Ratio
0.301.170.841.240.782.54